Roche Video News: New Hope for Arthritis Patients with Treatment Four Times More Likely to Halt Progression
Rheumatoid Arthritis often starts during the prime of a person’s working life, typically between the age of 35 and 45. Women are 3 times more likely to develop the disease than men. It is an incurable, painful and debilitating auto-immune disease where the body attacks itself, most noticeably in the joints. The total direct and indirect cost of RA in the UK is estimated to cost up to £4.75bn per year.
In this video: Leading experts in the treatment of Rheumatoid Arthritis provide an outline of the disease is and what the current treatment options are to those living with the condition. The experts go on to explain what the new smart drug RoActermra is and why the latest clinical data is so important.
Or if you're already a Pharma IQ member, sign in below to download. Sign In Join
Have Your Say
Rate this feature and give us your feedback in the comments section below